Close
provider
Search result for "Solr search content"
Search Result for "hematology"
provider
Matthew Butler, M.D. Hematology/Oncology, Internal Medicine
provider
Bruce Christensen, PA-C Hematology Oncology , Physician Assistant
provider
Deanna Maida, M.D. Pediatric Hematology, Pediatric Oncology
provider
Anne–Marie Langevin, MD Pediatric Hematology/Oncology, Pediatrics
provider
Robyn Scherber, M.D. Hematology, Internal Medicine
provider
Jane Mattei, MD, PhD Hematology Oncology, Melanoma Medical Oncology
Feb
17
provider
Devi Meyyappan, MD Hematology Oncology, Head & Neck Oncology, Geriatric Oncology
Clinical Trial
A Multicenter Phase 1 Study to Determine the Maximum Tolerated Dose/ Maximum Feasible Dose, Safety, and Efficacy of Single Dose Rhenium-186 NanoLiposome (186RNL) Administered via Intraventricular Catheter for Leptomeningeal Metastases (CTMS# 21-0138)
This is an open-label, multicenter, Phase 1 dose-escalation study to establish the safety and tolerability of a single dose of 186RNL by the intraventricular route (via intraventricular catheter) and to identify a maximum tolerated dose (MTD) and/or maximum feasible dose (MFD).